间歇性缺氧预治疗加剧了室内灰尘引发的喘呼吸道炎症
Hao Meng1, Dongxue Zhang2, Yifan Que1
1Health Management Institute, The Second Medical Center & National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Medical School of Chinese PLA, Beijing, China.
Immunity, inflammation and disease
|April 17, 2024
概括
间歇性缺氧预条件 (IHP) 可能通过增加气道炎症和NF-κB激活,特别是高剂量的过敏原,使室内灰尘引发的喘恶化.
科学领域:
- 肺部医学 肺部医学
- 免疫学 免疫学 免疫学
- 环境健康 环境健康
背景情况:
- 喘是一种炎症性疾病,其中缺氧的作用尚未完全理解.
- 缺氧是一种常见的环境因素,可能会影响喘的发展和进展.
- 喘中的炎症微环境是研究的一个关键领域.
研究的目的:
- 在小鼠模型中研究间歇性缺氧预条件 (IHP) 对室内灰尘 (HDM) 诱导的喘的影响.
- 确定NF-κB信号在缺氧加重喘中的作用.
- 评估过敏原剂量是否影响低氧对喘的影响.
主要方法:
- 在小鼠中使用室内灰尘虫 (HDM) 提取物在23天内诱导喘.
- 小鼠被暴露在室内空气 (RA) 或间歇性缺氧 (IH) 中,有些人在缺氧之前接受了IHP.
- 评估了气道炎症标志物,粘液分泌,炎症细胞招募和NF-κB表达.
主要成果:
- 与RA和IH组相比,IHP显著加剧了呼吸道炎症和高反应性.
- 在IHP组中观察到炎症媒介和NF-κB表达的增加.
- 缺氧对喘的恶化作用在高剂量过敏原暴露时更加明显.
结论:
- 间歇性缺氧预条件 (IHP) 可以加剧喘中HDM诱导的气道炎症.
- NF-κB信号传递与缺氧诱导的喘恶化机制有关.
- 高剂量的过敏原暴露会放大缺氧对喘严重性的负面影响.
相关概念视频
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma: Pathogenesis and Management
391
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
391
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
284
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
284
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
240
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
240


